HQL Logo

Tekla Life Sciences Investors (HQL) 

NYSE
Market Cap
$369.23M
Sector
Financial Services
Industry
Asset Management
Rank in Sector
13 of 647
Rank in Industry
9 of 103

Largest Insider Buys in Sector

HQL Stock Price History Chart

HQL Stock Performance

About Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth …

Insider Activity of Tekla Life Sciences Investors

Over the last 12 months, insiders at Tekla Life Sciences Investors have bought $10.93M and sold $0 worth of Tekla Life Sciences Investors stock.

On average, over the past 5 years, insiders at Tekla Life Sciences Investors have bought $2.36M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Saba Capital Management, L.P. (10 percent owner) — $43.49M. Maher Bill (director) — $47,121. DiMartino Rose (director) — $31,060.

The last purchase of 650 shares for transaction amount of $9,991 was made by Maher Bill (director) on 2024‑08‑23.

List of Insider Buy and Sell Transactions, Tekla Life Sciences Investors

2024-08-23Purchasedirector
650
0.0026%
$15.37$9,991-2.24%
2024-07-16Purchasedirector
1,000
0.004%
$15.53$15,530-0.48%
2024-06-26Purchase10 percent owner
100
0.0004%
$14.07$1,407+9.01%
2024-06-24Purchase10 percent owner
13,812
0.0499%
$14.08$194,473+8.23%
2024-06-13Purchase10 percent owner
8,467
0.03%
$13.82$117,014+10.45%
2024-06-12Purchase10 percent owner
2,400
0.0085%
$13.88$33,312+10.32%
2024-06-11Purchase10 percent owner
2,039
0.0072%
$13.76$28,057+11.09%
2024-06-10Purchase10 percent owner
9,704
0.0341%
$13.71$133,042+11.53%
2024-06-07Purchase10 percent owner
3,763
0.0132%
$13.72$51,628+11.31%
2024-06-06Purchase10 percent owner
9,598
0.034%
$13.80$132,452+11.36%
2024-06-05Purchase10 percent owner
26,083
0.092%
$13.76$358,902+10.93%
2024-06-04Purchase10 percent owner
33,357
0.1155%
$13.50$450,320+13.39%
2024-05-31Purchase10 percent owner
21,369
0.0728%
$13.29$283,994+14.86%
2024-05-30Purchase10 percent owner
669
0.0022%
$13.05$8,730+16.31%
2024-05-29Purchase10 percent owner
38,033
0.1276%
$13.09$497,852+17.13%
2024-05-28Purchase10 percent owner
8,714
0.0299%
$13.38$116,593+15.57%
2024-05-23Purchase10 percent owner
1,303
0.0045%
$13.50$17,591+13.42%
2024-05-15Purchase10 percent owner
34,755
0.1264%
$14.19$493,173+10.83%
2024-05-10Purchase10 percent owner
57,862
0.2056%
$13.86$801,967+13.99%
2024-05-09Purchase10 percent owner
17,373
0.0615%
$13.80$239,747+14.22%

Insider Historical Profitability

11.45%
Saba Capital Management, L.P.10 percent owner
3429991
12.5409%
$13.50310
Maher Billdirector
1715
0.0063%
$13.5020
Goetz Kathleendirector
1085
0.004%
$13.5030<0.0001%
Reit Todddirector
1000
0.0037%
$13.5010
DiMartino Rosedirector
1000
0.0037%
$13.5010

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.